Elevated plasma asymmetric dimethyl‐L‐arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis

• Published in: Arthritis and rheumatism 2007-03, Vol.56 (3), p.809-819
• Main Authors: Surdacki, Andrzej, Martens‐Lobenhoffer, Jens, Wloch, Alicja, Marewicz, Ewa, Rakowski, Tomasz, Wieczorek‐Surdacka, Ewa, Dubiel, Jacek S., Pryjma, Juliusz, Bode‐Böger, Stefanie M.
• Format: Article
• Language: English
• Subjects: Adult; Arginine - analogs & derivatives; Arginine - blood; Arthritis, Rheumatoid - complications; Arthritis, Rheumatoid - pathology; Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Carotid Arteries - diagnostic imaging; Carotid Arteries - pathology; Carotid Artery Diseases - etiology; Carotid Artery Diseases - pathology; Case-Control Studies; Cell Count; Diseases of the osteoarticular system; Endothelial Cells - pathology; Female; Humans; Inflammatory joint diseases; Male; Medical sciences; Mesenchymal Stromal Cells - pathology; Middle Aged; Nitric Oxide - metabolism; Ultrasonography
• ISSN: 0004-3591; 1529-0131
• DOI: 10.1002/art.22424

Objective Similarities between rheumatoid arthritis (RA) and atherosclerosis include endothelial dysfunction (an antecedent of plaque formation) and depletion of circulating bone marrow–derived endothelial progenitor cells. This study was undertaken to test the hypothesis that endothelial progenitor cell depletion and subclinical atherosclerosis in RA may be related to accumulation of an endogenous inhibitor of nitric oxide (NO) synthesis, asymmetric dimethyl‐L‐arginine. Methods We studied 30 patients with active RA and 20 age‐ and sex‐matched healthy controls. Exclusion criteria were clinically evident atherosclerosis, traditional risk factors, hyperhomocysteinemia, and renal dysfunction. The blood endothelial progenitor cell count was assayed by flow cytometry and expressed as a percentage of lymphocytes. Plasma L‐arginine, asymmetric dimethyl‐L‐arginine, and symmetric dimethyl‐L‐arginine were measured with liquid chromatography–mass spectrometry. Mean carotid intima‐media thickness (IMT) was assessed by B‐mode ultrasound. Results In RA patients, we found elevated levels of asymmetric dimethyl‐L‐arginine (mean ± SD 0.49 ± 0.07 μmoles/liter versus 0.40 ± 0.07 μmoles/liter in controls; P < 0.001), a depressed endothelial progenitor cell count (0.039 ± 0.025% versus 0.063 ± 0.035%; P < 0.05), and increased IMT (0.65 ± 0.13 mm versus 0.55 ± 0.10 mm; P < 0.01), with no differences in levels of L‐arginine or symmetric dimethyl‐L‐arginine. The endothelial progenitor cell count was inversely correlated with the level of asymmetric dimethyl‐L‐arginine. IMT was positively related to the ratio of asymmetric dimethyl‐L‐arginine to L‐arginine and negatively related to the endothelial progenitor cell count, in univariate and multivariate analyses. Conclusion Plasma asymmetric dimethyl‐L‐arginine levels are elevated in RA patients free of cardiovascular disease or risk factors. Asymmetric dimethyl‐L‐arginine accumulation may contribute to endothelial progenitor cell depletion via depressed NO‐dependent endothelial progenitor cell mobilization and/or survival, with consequent impairment of endothelial progenitor cell–mediated endothelial repair, which can promote atherogenesis in RA.